These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 21904790)

  • 41. Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I.
    Penati R; Fumagalli F; Calbi V; Bernardo ME; Aiuti A
    J Inherit Metab Dis; 2017 Jul; 40(4):543-554. PubMed ID: 28560469
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Role of neural precursor cells in promoting repair following stroke.
    Dibajnia P; Morshead CM
    Acta Pharmacol Sin; 2013 Jan; 34(1):78-90. PubMed ID: 23064725
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time associated decline in neurotrophic properties of neural stem cell grafts render them dependent on brain region-specific environmental support.
    Fainstein N; Cohen ME; Ben-Hur T
    Neurobiol Dis; 2013 Jan; 49():41-8. PubMed ID: 22910454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Successful hematopoietic stem cell transplantation in Farber disease.
    Vormoor J; Ehlert K; Groll AH; Koch HG; Frosch M; Roth J
    J Pediatr; 2004 Jan; 144(1):132-4. PubMed ID: 14722533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New perspectives of tissue remodelling with neural stem and progenitor cell-based therapies.
    Cossetti C; Alfaro-Cervello C; Donegà M; Tyzack G; Pluchino S
    Cell Tissue Res; 2012 Jul; 349(1):321-9. PubMed ID: 22322425
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induced Pluripotent Stem Cells for Disease Modeling and Evaluation of Therapeutics for Niemann-Pick Disease Type A.
    Long Y; Xu M; Li R; Dai S; Beers J; Chen G; Soheilian F; Baxa U; Wang M; Marugan JJ; Muro S; Li Z; Brady R; Zheng W
    Stem Cells Transl Med; 2016 Dec; 5(12):1644-1655. PubMed ID: 27484861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transplantation of Neural Progenitors and V2a Interneurons after Spinal Cord Injury.
    Zholudeva LV; Iyer N; Qiang L; Spruance VM; Randelman ML; White NW; Bezdudnaya T; Fischer I; Sakiyama-Elbert SE; Lane MA
    J Neurotrauma; 2018 Dec; 35(24):2883-2903. PubMed ID: 29873284
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gene therapy for the neurological manifestations in lysosomal storage disorders.
    Cheng SH
    J Lipid Res; 2014 Sep; 55(9):1827-38. PubMed ID: 24683200
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparing neural stem/progenitor cells in PuraMatrix hydrogel for transplantation after brain injury in rats: A comparative methodological study.
    Aligholi H; Rezayat SM; Azari H; Ejtemaei Mehr S; Akbari M; Modarres Mousavi SM; Attari F; Alipour F; Hassanzadeh G; Gorji A
    Brain Res; 2016 Jul; 1642():197-208. PubMed ID: 27038753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term selective stimulation of transplanted neural stem/progenitor cells for spinal cord injury improves locomotor function.
    Kawai M; Imaizumi K; Ishikawa M; Shibata S; Shinozaki M; Shibata T; Hashimoto S; Kitagawa T; Ago K; Kajikawa K; Shibata R; Kamata Y; Ushiba J; Koga K; Furue H; Matsumoto M; Nakamura M; Nagoshi N; Okano H
    Cell Rep; 2021 Nov; 37(8):110019. PubMed ID: 34818559
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Strategies to Enhance Implantation and Survival of Stem Cells After Their Injection in Ischemic Neural Tissue.
    Sandvig I; Gadjanski I; Vlaski-Lafarge M; Buzanska L; Loncaric D; Sarnowska A; Rodriguez L; Sandvig A; Ivanovic Z
    Stem Cells Dev; 2017 Apr; 26(8):554-565. PubMed ID: 28103744
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Systemic injection of neural stem/progenitor cells in mice with chronic EAE.
    Donegà M; Giusto E; Cossetti C; Schaeffer J; Pluchino S
    J Vis Exp; 2014 Apr; (86):. PubMed ID: 24798882
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Role of Exosomes in Lysosomal Storage Disorders.
    Gleason AM; Woo EG; McKinney C; Sidransky E
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33920837
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis.
    Selden NR; Al-Uzri A; Huhn SL; Koch TK; Sikora DM; Nguyen-Driver MD; Guillaume DJ; Koh JL; Gultekin SH; Anderson JC; Vogel H; Sutcliffe TL; Jacobs Y; Steiner RD
    J Neurosurg Pediatr; 2013 Jun; 11(6):643-52. PubMed ID: 23581634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The basics of lysosomal storage diseases].
    Tamò R; Rohrbach M; Baumgartner M; Beuschlein F; Nowak A
    Ther Umsch; 2018 Nov; 75(4):199-207. PubMed ID: 30468118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic approaches for neuronopathic lysosomal storage disorders.
    Schiffmann R
    J Inherit Metab Dis; 2010 Aug; 33(4):373-9. PubMed ID: 20162366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential of neural stem cell-based therapies for Alzheimer's disease.
    Li XY; Bao XJ; Wang RZ
    J Neurosci Res; 2015 Sep; 93(9):1313-24. PubMed ID: 25601591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional neural transplantation III. Primary and stem cell therapies for brain repair, part I. Introduction.
    Dunnett SB; Björklund A
    Prog Brain Res; 2012; 200():3-5. PubMed ID: 23195411
    [No Abstract]   [Full Text] [Related]  

  • 59. Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications.
    Biffi A
    Mol Ther; 2017 May; 25(5):1155-1162. PubMed ID: 28389320
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Methods of reactivation and reprogramming of neural stem cells for neural repair.
    Tian Z; Zhao Q; Biswas S; Deng W
    Methods; 2018 Jan; 133():3-20. PubMed ID: 28864354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.